 Allison Shapiro
Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adiposity | 9 | 2022 | 458 | 1.800 |
Why?
| | Maternal Nutritional Physiological Phenomena | 5 | 2023 | 141 | 1.580 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2024 | 2096 | 1.150 |
Why?
| | Obesity | 9 | 2022 | 2508 | 1.090 |
Why?
| | Cognition | 8 | 2024 | 989 | 1.080 |
Why?
| | Feeding Behavior | 3 | 2019 | 574 | 0.910 |
Why?
| | Overweight | 2 | 2020 | 472 | 0.900 |
Why?
| | Insulin Resistance | 3 | 2024 | 1072 | 0.890 |
Why?
| | Insulin | 5 | 2024 | 2080 | 0.850 |
Why?
| | Prenatal Exposure Delayed Effects | 6 | 2023 | 452 | 0.830 |
Why?
| | Language Development | 2 | 2024 | 59 | 0.820 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 3 | 2017 | 57 | 0.810 |
Why?
| | Executive Function | 3 | 2024 | 380 | 0.800 |
Why?
| | Hunger | 2 | 2019 | 37 | 0.770 |
Why?
| | Prediabetic State | 1 | 2024 | 219 | 0.740 |
Why?
| | Mothers | 5 | 2024 | 651 | 0.730 |
Why?
| | Blood Glucose | 6 | 2022 | 1828 | 0.730 |
Why?
| | Adipogenesis | 2 | 2016 | 42 | 0.650 |
Why?
| | Brain | 2 | 2020 | 2371 | 0.600 |
Why?
| | Umbilical Cord | 3 | 2017 | 80 | 0.580 |
Why?
| | Birth Weight | 9 | 2022 | 440 | 0.580 |
Why?
| | Niacin | 1 | 2017 | 18 | 0.580 |
Why?
| | Reward | 1 | 2019 | 211 | 0.550 |
Why?
| | Body Composition | 6 | 2017 | 590 | 0.540 |
Why?
| | Pregnancy | 16 | 2023 | 5518 | 0.540 |
Why?
| | Niacinamide | 1 | 2016 | 63 | 0.520 |
Why?
| | Diet, High-Fat | 1 | 2017 | 225 | 0.520 |
Why?
| | Caregivers | 1 | 2022 | 717 | 0.500 |
Why?
| | Body Mass Index | 10 | 2022 | 1959 | 0.440 |
Why?
| | Diabetes, Gestational | 1 | 2017 | 281 | 0.420 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2023 | 3252 | 0.410 |
Why?
| | Magnetic Resonance Imaging | 2 | 2020 | 3053 | 0.400 |
Why?
| | Child, Preschool | 10 | 2024 | 9116 | 0.390 |
Why?
| | Health Behavior | 1 | 2017 | 704 | 0.380 |
Why?
| | Cohort Studies | 6 | 2021 | 4895 | 0.370 |
Why?
| | Cannabinoids | 2 | 2023 | 115 | 0.370 |
Why?
| | Female | 26 | 2024 | 59511 | 0.350 |
Why?
| | Infant, Newborn | 10 | 2019 | 5047 | 0.340 |
Why?
| | Biomarkers | 1 | 2019 | 3408 | 0.320 |
Why?
| | Plethysmography | 4 | 2017 | 103 | 0.320 |
Why?
| | Longitudinal Studies | 6 | 2024 | 2387 | 0.310 |
Why?
| | Diet Surveys | 3 | 2017 | 78 | 0.300 |
Why?
| | Humans | 30 | 2024 | 114689 | 0.300 |
Why?
| | Language | 2 | 2022 | 263 | 0.300 |
Why?
| | Diet | 5 | 2023 | 1080 | 0.300 |
Why?
| | Child Development | 2 | 2024 | 385 | 0.290 |
Why?
| | Cognition Disorders | 2 | 2024 | 476 | 0.290 |
Why?
| | Child | 9 | 2024 | 18415 | 0.280 |
Why?
| | Adult | 14 | 2024 | 30550 | 0.270 |
Why?
| | Young Adult | 9 | 2024 | 10470 | 0.270 |
Why?
| | Male | 17 | 2024 | 55599 | 0.270 |
Why?
| | Cannabis | 2 | 2023 | 384 | 0.260 |
Why?
| | Diabetic Neuropathies | 2 | 2023 | 79 | 0.240 |
Why?
| | PPAR gamma | 2 | 2016 | 182 | 0.240 |
Why?
| | Infant | 8 | 2022 | 7963 | 0.230 |
Why?
| | Prospective Studies | 6 | 2023 | 6220 | 0.220 |
Why?
| | Adolescent | 8 | 2024 | 17848 | 0.220 |
Why?
| | Glucose Tolerance Test | 1 | 2024 | 343 | 0.210 |
Why?
| | Follow-Up Studies | 2 | 2024 | 4411 | 0.200 |
Why?
| | Vocabulary | 1 | 2022 | 41 | 0.200 |
Why?
| | Cannabidiol | 1 | 2023 | 60 | 0.200 |
Why?
| | Educational Status | 1 | 2024 | 412 | 0.190 |
Why?
| | Weight Gain | 2 | 2015 | 453 | 0.190 |
Why?
| | Hallucinogens | 1 | 2023 | 73 | 0.190 |
Why?
| | Colorado | 7 | 2019 | 4099 | 0.190 |
Why?
| | Diabetes Complications | 1 | 2023 | 211 | 0.190 |
Why?
| | Food | 1 | 2022 | 160 | 0.180 |
Why?
| | Maternal Inheritance | 1 | 2020 | 15 | 0.180 |
Why?
| | Insulin-Secreting Cells | 1 | 2024 | 317 | 0.170 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 133 | 0.170 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2023 | 245 | 0.170 |
Why?
| | Hyperphagia | 1 | 2019 | 28 | 0.160 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 284 | 0.160 |
Why?
| | Energy Intake | 2 | 2023 | 427 | 0.150 |
Why?
| | Maternal Exposure | 1 | 2019 | 138 | 0.150 |
Why?
| | Neurodevelopmental Disorders | 1 | 2019 | 110 | 0.150 |
Why?
| | Dietary Supplements | 1 | 2021 | 460 | 0.150 |
Why?
| | Fasting | 1 | 2019 | 241 | 0.150 |
Why?
| | Satiation | 1 | 2017 | 22 | 0.140 |
Why?
| | Tobacco Smoke Pollution | 1 | 2019 | 217 | 0.140 |
Why?
| | Regression Analysis | 1 | 2019 | 945 | 0.130 |
Why?
| | Fetal Development | 2 | 2016 | 246 | 0.130 |
Why?
| | Pediatric Obesity | 3 | 2017 | 489 | 0.130 |
Why?
| | Sirtuin 1 | 1 | 2016 | 29 | 0.130 |
Why?
| | Infant, Small for Gestational Age | 1 | 2017 | 76 | 0.130 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2017 | 172 | 0.130 |
Why?
| | Lipids | 2 | 2021 | 580 | 0.130 |
Why?
| | Socioeconomic Factors | 2 | 2017 | 1078 | 0.130 |
Why?
| | Fetal Blood | 1 | 2017 | 270 | 0.130 |
Why?
| | Homeostasis | 1 | 2019 | 573 | 0.130 |
Why?
| | Dietary Carbohydrates | 1 | 2016 | 138 | 0.120 |
Why?
| | Sense of Coherence | 1 | 2015 | 13 | 0.120 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2015 | 77 | 0.120 |
Why?
| | Dietary Proteins | 1 | 2016 | 122 | 0.120 |
Why?
| | Prenatal Care | 1 | 2017 | 253 | 0.120 |
Why?
| | Neuropsychological Tests | 1 | 2019 | 927 | 0.120 |
Why?
| | Psychological Tests | 1 | 2015 | 120 | 0.120 |
Why?
| | Fatty Acids | 1 | 2017 | 381 | 0.120 |
Why?
| | Risk Factors | 5 | 2021 | 8632 | 0.120 |
Why?
| | Dietary Fats | 1 | 2016 | 287 | 0.120 |
Why?
| | Vitamin D | 1 | 2017 | 341 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 797 | 0.110 |
Why?
| | beta Catenin | 1 | 2015 | 219 | 0.110 |
Why?
| | Maternal-Fetal Exchange | 1 | 2015 | 151 | 0.110 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 993 | 0.110 |
Why?
| | Linear Models | 4 | 2017 | 768 | 0.110 |
Why?
| | DNA Methylation | 1 | 2017 | 495 | 0.110 |
Why?
| | Parents | 1 | 2021 | 1186 | 0.110 |
Why?
| | Surveys and Questionnaires | 4 | 2017 | 4623 | 0.110 |
Why?
| | Gene Expression | 1 | 2017 | 1421 | 0.100 |
Why?
| | Smoking | 1 | 2019 | 1383 | 0.100 |
Why?
| | Pregnancy Complications | 1 | 2015 | 429 | 0.090 |
Why?
| | Blood Pressure | 1 | 2017 | 1538 | 0.090 |
Why?
| | Indians, North American | 1 | 2015 | 570 | 0.080 |
Why?
| | Energy Metabolism | 1 | 2015 | 731 | 0.080 |
Why?
| | Aged | 2 | 2024 | 19074 | 0.070 |
Why?
| | Exercise | 1 | 2017 | 1644 | 0.070 |
Why?
| | Muscle Development | 2 | 2017 | 98 | 0.070 |
Why?
| | Middle Aged | 2 | 2024 | 26737 | 0.060 |
Why?
| | Cardiovascular Diseases | 1 | 2015 | 1727 | 0.060 |
Why?
| | Sugars | 1 | 2023 | 29 | 0.050 |
Why?
| | Family Characteristics | 1 | 2023 | 151 | 0.050 |
Why?
| | United States | 1 | 2016 | 12183 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2017 | 1701 | 0.040 |
Why?
| | Diabetic Retinopathy | 1 | 2021 | 149 | 0.040 |
Why?
| | Breast Feeding | 1 | 2021 | 368 | 0.040 |
Why?
| | Diabetic Nephropathies | 1 | 2021 | 234 | 0.040 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 33 | 0.040 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2017 | 43 | 0.040 |
Why?
| | Glucose | 1 | 2022 | 897 | 0.040 |
Why?
| | Pregnancy Trimester, Second | 1 | 2017 | 66 | 0.030 |
Why?
| | Pregnancy Trimester, Third | 1 | 2017 | 79 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2017 | 122 | 0.030 |
Why?
| | Mental Recall | 1 | 2017 | 171 | 0.030 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2015 | 60 | 0.030 |
Why?
| | Lipoproteins, HDL | 1 | 2015 | 75 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2015 | 257 | 0.030 |
Why?
| | Gestational Age | 1 | 2017 | 760 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2017 | 444 | 0.030 |
Why?
| | Health | 1 | 2015 | 74 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2017 | 923 | 0.030 |
Why?
| | Leptin | 1 | 2015 | 210 | 0.030 |
Why?
| | Incidence | 1 | 2019 | 2313 | 0.030 |
Why?
| | Oral Health | 1 | 2015 | 140 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 4410 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1430 | 0.030 |
Why?
| | Triglycerides | 1 | 2015 | 467 | 0.030 |
Why?
| | Metabolomics | 1 | 2017 | 521 | 0.030 |
Why?
| | Self Efficacy | 1 | 2015 | 355 | 0.020 |
Why?
| | Logistic Models | 1 | 2017 | 1841 | 0.020 |
Why?
| | Psychometrics | 1 | 2015 | 608 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2017 | 1076 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2017 | 1019 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1518 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2014 | 545 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2320 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 3886 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2015 | 2765 | 0.020 |
Why?
| | Quality of Life | 1 | 2015 | 2353 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2015 | 6347 | 0.010 |
Why?
|
|
Shapiro's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|